Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-059246

SVP & General Counsel sold 1,539 shares at $16.93 ($26,055)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2020-11-16 Sale −1,539 $16.93 $26,055 49,850 D
Open-market sales · 1,539 sh · avg $16.93 · $26,055
Loading xslF345X03/doc4.xml…